TTrialPathMatch Me to Trials
← Back to trials
RecruitingEndometrial Carcinoma

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Eligible age

45+ yrs

Accepts

Women

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Sponsor: Mayo Clinic

You may qualify if…

  • ✓ Self-identified Black individuals ≥ 45 years with an intact uterus
  • ✓ Assigned female sex at birth
  • ✓ Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
  • ✓ Willing to participate in a 45-minute virtual interview

You may not qualify if…

  • ✕ Previous or current diagnosis of endometrial cancer

Where it's recruiting

Minnesota

Rochester

Source: ClinicalTrials.gov · NCT07527143 · last updated 2026-07-09

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detectio · TrialPath